Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: In the Randomized Phase, to evaluate the preliminary efficacy and tolerability of multiple regimens of XL184 Measure: In the Expansion Phase, to evaluate the efficacy of XL184 treatment. After: Measure: Randomized Phase: Number of Participants With Treatment Emergent Adverse Events (TEAEs) Measure: Expansion Phase: Objective Response Rate (ORR).
Recruitment status changed
Before: Completed. After: Terminated.